Co-infection of hepatitis B and hepatitis C virus in human immunodeficiency virus-infected patients in New York City, United States

Table 2 Multiple logistic regression analysis of factors associated with HIV/HBV, HIV/HCV, and HIV/HBV/HCV co-infection

	HIV/HBV		HIV/HCV		HIV/HBV/HCV
Characteristics	OR (95% CI)	P	OR (95% CI)	P	OR (95% CI)	P
Gender
Female (Ref)
Male	1.711 (1.179-2.482)	0.005	1.241 (1.052-1.464)	0.011	2.156 (1.159-4.011)	0.015
Male->Female or Female->Male	0.399 (0.053-3.020)	0.374	1.978 (0.939-4.167)	0.073	2.091 (0.250-17.529)	0.496
Ethnic group
White (Ref)
Hispanic	0.766 (0.480-1.222)	0.263	0.956 (0.761-1.201)	0.699	0.915 (0.492-1.702)	0.779
Black	2.091 (1.404-3.114)	< 0.001	0.788 0.631-0.984)	0.036	0.851 (0.464-1.561)	0.602
Other	0.811 (0.309-2.125)	0.670	0.827 (0.493-1.388)	0.473	0.000 (0.000- . )	0.996
Risk factor of HIV aquisition
Hetero (Ref)
MSM	1.747 (1.247-2.448)	0.001	0.565 (0.446-0.715)	< 0.001	1.798 (0.763-4.238)	0.180
Hetero and MSM	1.371 (0.408-4.606)	0.610	0.000 (0.000- . )	0.998	0.000 (0.000- . )	0.998
IDU	0.114 (0.049-0.262)	< 0.001	8.956 (7.502-10.693)	< 0.001	6.345 (3.015-13.351)	< 0.001
IDU and hetero	0.247 (0.077-0.789)	0.018	9.106 (6.905-12.007)	< 0.001	9.731 (4.082-23.196)	< 0.001
IDU and MSM	0.714 (0.217-2.344)	0.578	9.179 (5.767-14.609)	< 0.001	9.228 (2.897-29.391)	< 0.001
IDU and hetero and MSM	0.000 (0.000- . )	0.999	0.900 (0.107-7.550)	0.923	0.000 (0.000- . )	0.999
Transfusion	1.161 (0.354-3.807)	0.806	3.224 (1.866-5.572)	< 0.001	0.000 (0.000- . )	0.998
Perinatal	0.000 (0.000- . )	0.996	0.000 (0.000- . )	0.996	0.000 (0.000- . )	0.997
Other	0.594 (0.080-4.437)	0.612	0.000 (0.000- . )	0.998	5.857 (0.715-47.994)	0.100
Unknown	1.984 (1.249-3.153)	0.004	0.703 (0.476-1.039)	0.077	4.219 (1.478-12.044)	0.007